You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Filter results
You can narrow down the results using the filters
Topic
- Alert/Advisory (1066)
- Medicines safety (465)
- Medical devices safety (326)
- Medicines (56)
- Shortages (34)
- Safety (13)
- Prescription medicines (10)
- Blood safety (8)
- Medical devices (8)
- Unapproved therapeutic goods (5)
- Listed medicines (4)
- Advertising (2)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Import and export (2)
- Legislation (2)
- Over the counter medicine (2)
- Regulatory compliance (2)
- Biologicals (1)
- Breast implant hub (1)
- Clinical trials (1)
- Complementary medicines (1)
- Labelling and packaging (1)
- Non-prescription medicines (1)
- Therapeutic goods regulation (1)
Search
1217 result(s) found, displaying 1 to 25
- Medicine shortage alertsAntibiotics shortage update and new guidance for health professionalsWe have updated the information about these shortages with new details about affected products and a link to an additional resource for health professionals.
- Safety alertsRisk of kidney damage with oral anticoagulantsA warning about serious kidney damage has been added to the prescribing information for all oral anticoagulants in Australia.
- Safety alertsEVE Allylisopropylacetylurea tabletsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
- Safety alertsCounterfeit semaglutide vialsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
- Medicine shortage alertsHydrocortisone shortageThe TGA is aware of a shortage of all hydrocortisone tablet strengths due to manufacturing issues. We are working with the supplier Alphapharm Pty Ltd to manage the impact.
- Safety alertsNew safety warning for medicines used in arthritis and other inflammatory conditionsA safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.
- Medicine shortage alertsAntibiotics shortage update and substitution allowed to address shortage of cefaclorWe continue to monitor antibiotic medicines in shortage and are seeking and prioritising applications for overseas alternatives to assist with supply.
- Product recallsFreeStyle LibreLink Android AppUsers may experience extended periods of signal loss and during this time they won’t receive high or low glucose alarms.
- Product recallsEvolutTM PRO+34mm Transcatheter Aortic Valve (TAV)Medtronic Australasia is informing customers about the serious risk of valve infolding for EvolutePRO+ 34mm Transcatheter Aortic Valve (TAV), item code - EVPROPLUS-34US.
- Medicine shortage alertsSubstitution allowed to address shortage of phenoxymethylpenicillinTo help manage the shortage of the antibiotic phenoxymethylpenicillin (Penicillin V), we have made a Serious Scarcity Substitution Instrument (SSSI).
- Product recallsMetal fragment found in an Ultra Potent-C Chewable TabletBioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.
- Medicine shortage alertsTenecteplase (Metalyse) shortage shelf-life extension expandedA 12-month shelf-life extension is now in place for all batches with an original expiry date from January 2022 to March 2025.
- Safety alertsNitrosamine impurities in medicines - Information for sponsors and manufacturersRead updated information on nitrosamine impurities, the TGA response and requirements for medicine sponsors and manufacturers.
- Medicine shortage alertsSubstitution instrument to address shortage of COUMADIN warfarin 5mg tabletsAs the shortage of Coumadin 5mg tablets is expected to continue, the TGA has made a Serious Scarcity Substitution Instrument to assist patients to access their medicine from their pharmacist without delay or interruption to treatment.
- Medicine shortage alertsAntibiotics shortagesInformation about the shortage of some antibiotics, including amoxicillin and metronidazole medicines
- Medicine shortage alertsWarfarin shortagesThe TGA is aware of several warfarin product shortages due to manufacturing issues.
- Safety alertsPholcodineThe TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.
- Product recallsCurash Nappy Rash CreamChurch and Dwight are recalling two batches of Curash Nappy Rash Cream, following reports of adverse reactions
- Medicine shortage alertsUpdate: Limited semaglutide (Ozempic) supplyThere remains an increased global demand for semaglutide products which is impacting availability and certainty of supply of Ozempic (semaglutide) in Australia until early 2023.
- Medicine shortage alertsShortage of tenecteplase (Metalyse)Boehringer Ingelheim (BI) has advised the TGA of a shortage of tenecteplase (Metalyse) injection that is predicted to extend over the next 18 months.
- Safety alertsBreast implants and anaplastic large cell lymphomaUpdate - Suspended breast implant devices now cancelled
- Product recallsHeartStart Automated External Defibrillators (AED) - UpdatePhilips has advised that corrected pads will be shipped in early 2023 to customers affected by the problem.
- Medicine shortage alertsNationwide shortage of certain antibiotics - updateThe shortages list of antibiotics has been updated.
- Medicine shortage alertsJoint statement: Prioritisation of semaglutide (Ozempic) supply for people with type 2 diabetes during shortageJoint statement on the Ozempic (semaglutide) shortage and prioritisation for people with type 2 diabetes.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »